• 1
    Aframian DJ, Cukierman E, Nikolovski J, Mooney DJ, Yamada KM, Baum BJ (2000). The growth and morphological behavior of salivary epithelial cells on matrix protein-coated biodegradable substrata. Tissue Eng 8: 209216.
  • 2
    Allweiss P, Braunstein GD, Katz A, Waxman A (1984). Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med 8: 755758.
  • 3
    Almstahl A, Kroneld U, Tarkowski A, Wikstrom M (1999). Oral microbial flora in Sjogren's syndrome. J Rheum 8: 110114.
  • 4
    Almstahl A, Wikstrom M (1999). Oral microflora in subjects with reduced salivary secretion. J Dent Res 8: 14101416.
  • 5
    Anastassov GE, Haiavy J, Solodnik P, Lee H, Lumerman H (2000). Submandibular gland mucocele: diagnosis and management. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 159163.
  • 6
    Andersen SW, Machin D (1997). Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncol 8: 146147.
  • 7
    Arneberg P, Bjertness E, Storhaug K, Glennas A, Bjerkhoel F (1992). Remaining teeth, oral dryness and dental health habits in middle-aged Norwegian rheumatoid arthritis patients. Comm Dent Oral Epidemiol 8: 292296.
  • 8
    Atkinson JC, Baum BJ (2001). Salivary enhancement: current status and future therapies. J Dent Educ 8: 10961101.
  • 9
    Atkinson JC, Fox PC (1992). Salivary gland dysfunction. Clin Geriatr Med 8: 499511.
  • 10
    Atkinson JC, Wu A (1994). Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc 8: 409416.
  • 11
    August M, Wang J, Plante D, Wang CC (1996). Complications associated with therapeutic neck radiation. J Oral Maxillofac Surg 8: 14091415; Discussion 14156.
  • 12
    Baum BJ (1981). Evaluation of stimulated parotid saliva flow rate in different age groups. J Dent Res 8: 12921296.
  • 13
    Baum BJ, Ship JA, Wu AJ (1992). Salivary gland function and aging: a model for studying the interaction of aging and systemic disease. CRC Crit Rev Oral Biol Med 8: 5364.
  • 14
    Baum BJ, Dai Y, Hiramatsu Y, Horn VJ, Ambudkar IS (1993). Signaling mechanisms that regulate saliva formation. Crit Rev Oral Biol Medical 8: 379384.
  • 15
    Baum BJ, Wang S, Cukierman E et al (1999). Re-engineering the functions of a terminally differentiated epithelial cell in vivo. Ann NY Acad Sci 8: 294300.
  • 16
    Baum BJ, Goldsmith CM, Hoque AT et al (2000). Salivary glands as a model for craniofacial applications of gene transfer. Int J Oral Max Surg 8: 163166.
  • 17
    Bell M, Askari A, Bookman A et al (1999). Sjogren's syndrome: a critical review of clinical management. J Rheum 8: 20512061.
  • 18
    Bergdahl M, Bergdahl J (2000). Low unstimulated salivary flow and subjective oral dryness: association with medication, anxiety, depression, and stress. J Dent Res 8: 16521658.
  • 19
    Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ (1992). Sjogren's syndrome. A clinical, pathological, and serological study of sixty-two cases 1965. Medicine 8: 386401.
  • 20
    Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar-Mansson B (1996). Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncol, Eur J Cancer 8: 182190.
  • 21
    Blom M, Lundeberg T (2000). Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis 8: 1524.
  • 22
    Buntzel J, Kuttner K, Frohlich D, Glatzel M (1998a). Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 8: 505509.
  • 23
    Buntzel J, Schuth J, Kuttner K, Glatzel M (1998b). Radiochemotherapy with amifostine cytoprotection for head and neck cancer. Care Cancer 8 (Suppl.): 155160.
  • 24
    Cannon RD, Chaffin WL (1999). Oral colonization by Candida albicans. Crit Rev Oral Biol Med 8: 359383.
  • 25
    Capizzi RL, Oster W (2000). Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol 8: 425435.
  • 26
    Cevimeline. (2000). Cevimeline (Evoxac) for dry mouth. Med Ltr Drug Therap 8: 7070.
  • 27
    Challacombe SJ, Percival RS, Marsh PD (1995). Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals. Oral Micro Immunol 8: 202207.
  • 28
    Chancellor MB, Appell RA, Sathyan G, Gupta SK (2001). A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate. Clin Ther 8: 753760.
  • 29
    Chaushu G, Itzkovitz-Chaushu S, Yefenof E, Slavin S, Or R, Garfunkel AA (1995). A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 164169.
  • 30
    Chaushu G, Bercovici M, Dori S et al (2000). Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer 8: 984987.
  • 31
    Chavez EM, Taylor GW, Borrell LN, Ship JA (2000). Salivary function and glycemic control in older persons with diabetes. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 305311.
  • 32
    Chavez EM, Borrell LN, Taylor GW, Ship JA (2001). A longitudinal analysis of salivary flow in control subjects and older adults with type 2 diabetes. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 166173.
  • 33
    Conley RR, Tamminga CA, Bartko JJ et al (1998). Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia. Am J Psychiatr 8: 914920.
  • 34
    Daniels TE, Whitcher JP (1994). Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjogren's syndrome. Arthritis Rheum 8: 869877.
  • 35
    Davies AN (2000). A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med 8: 197203.
  • 36
    Davies AN, Daniels C, Pugh R, Sharma K (1998). A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med 8: 105111.
  • 37
    Davies AN, Singer J (1994). A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia. J Laryngol Otol 8: 663665.
  • 38
    Dawes C (1975). Circadian rhythms in the flow rate and composition of unstimulated and stimulated human submandibular saliva. J Physiol 8: 535548.
  • 39
    Dawes C (1987). Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res 8: 648653.
  • 40
    Dawes C, Macpherson LM (1992). Effects of nine different chewing-gums and lozenges on salivary flow rate and pH. Caries Res 8: 176182.
  • 41
    Dawson LA, Anzai Y, Marsh L et al (2000). Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Rad Oncol Biol Phys 8: 11171126.
  • 42
    Epstein JB, Chow AW (1999). Oral complications associated with immunosuppression and cancer therapies. Inf Dis Clin N Amer 8: 901923.
  • 43
    Epstein JB, Polsky B (1998). Oropharyngeal candidiasis: a review of its clinical spectrum and current therapies. Clin Therap 8: 4057.
  • 44
    Epstein JB, Stevenson-Moore P (1992). A clinical comparative trial of saliva substitutes in radiation-induced salivary gland hypofunction. Spec Care Dent 8: 2123.
  • 45
    Epstein JB, Burchell JL, Emerton S, Le ND, Silverman S (1994). A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A Pilot Study Oral Surg Oral Med Oral Path 8: 610614.
  • 46
    Eisbruch A, Ship JA, Martel MK et al (1996). Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Rad Oncol Biol Phys 8: 469480.
  • 47
    Eisbruch A, Marsh LH, Martel MK et al (1998). Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Rad Oncol Biol Phys 8: 559568.
  • 48
    Eisbruch A, Dawson LA, Kim HM et al (1999). Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Oto Rhino Laryng Belg 8: 271275.
  • 49
    Eisbruch A, Ship JA, Kim HM, Ten Haken RK (2001a). Partial irradiation of the parotid gland. Sem Rad Oncol 8: 234239.
  • 50
    Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA (2001). Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Rad Oncol, Biol, Phys 8(3): 695704.
  • 51
    Ettinger RL (1997). The unique oral health needs of an aging population. Dent Clin N Am 8: 633649.
  • 52
    Field EA, Longman LP, Bucknall R, Kaye SB, Higham SM, Edgar WM (1997). The establishment of a xerostomia clinic: a prospective study. Br J Oral Max Surg 8: 96103.
  • 53
    Fischer D, Ship JA (1997). The effect of dehydration on parotid salivary gland function. Spec Care Dent 8: 5864.
  • 54
    Fox PC (1997). Management of dry mouth. Dent Clin N Am 8: 863876.
  • 55
    Fox PC (1998). Acquired salivary dysfunction. Drugs Radiat Ann NY Acad Sci 8: 132137.
  • 56
    Fox RI (2000). Sjogren's syndrome: current therapies remain inadequate for a common disease. Exp Opin Invest Drugs 8: 1616.
  • 57
    Fox PC, Van Der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ (1985). Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 8: 519525.
  • 58
    Fox PC, Busch KA, Baum BJ (1987). Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 8: 581584.
  • 59
    Fox PC, Datiles M, Atkinson JC et al (1993). Prednisone and piroxicam for treatment of primary Sjogren's syndrome. Clin Exp Rheum 8: 149156.
  • 60
    Fox RI, Dixon R, Guarrasi V, Krubel S (1996). Treatment of primary Sjogren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 8 (Suppl. 1): S31S36.
  • 61
    Fox RI, Stern M, Michelson P (2000). Update in Sjogren syndrome. Curr Opin Rheum 8: 391398.
  • 62
    Ghezzi EM, Lange LA, Ship JA (2000). Determination of variation of stimulated salivary flow rates. J Dent Res 8: 18741878.
  • 63
    Gibson G, Barrett E (1992). The role of salivary function on oropharyngeal colonization. Spec Care Dent 8: 153156.
  • 64
    Gnepp DR (1993). Malignant mixed tumors of the salivary glands: a review. Pathol Annu 8: 279328.
  • 65
    Golden DP, Hooley JR (1994). Oral mucosal biopsy procedures. Excisional Incisional Dent Clin N Am 8: 279300.
  • 66
    Hamlar DD, Schuller DE, Gahbauer RA et al (1996). Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope 8: 972976.
  • 67
    Harrison T, Bigler L, Tucci M et al (1998). Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study. Spec Care Dent 8: 109112.
  • 68
    Heft MW, Baum BJ (1984). Unstimulated and stimulated parotid salivary flow rate in individuals of different ages. J Dent Res 8: 11821185.
  • 69
    Henson BS, Eisbruch A, D'Hondt E, Ship JA (1999). Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment. Oral Oncol 8: 234241.
  • 70
    Henson BS, Inglehart MR, Eisbruch A, Ship JA (2001). Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 8: 8493.
  • 71
    Hunter KD, Wilson WS (1995). The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol 8: 983989.
  • 72
    Jacobs CD, Van Der Pas M (1996). A multicenter maintenance Study of oral pilocarpine tablets for radiation-induced xerostomia. Oncology 8 (Suppl. 3): 1620.
  • 73
    Jacobsen FM, Comas-Diaz L (1999). Donepezil for psychotropic-induced memory loss. J Clin Psychiatr 8: 698704.
  • 74
    Jellema AP, Langendijk H, Bergenhenegouwen L et al (2001). The efficacy of xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-Study. Radiother Oncol 8: 157160.
  • 75
    Jensen JL, Karatsaidis A, Brodin P (1998). Salivary secretion: stimulatory effects of chewing-gum versus paraffin tablets. Europ J Oral Sci 8: 892896.
  • 76
    Johnson JT, Ferretti GA, Nethery WJ et al (1993). Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 8: 390395.
  • 77
    Kaplan MJ, Johns ME, Cantrell RW (1986). Chemotherapy for salivary gland cancer. Otolaryngol Head Neck Surg 8: 165170.
  • 78
    Kassan SS, Thomas TL, Moutsopoulos HM et al (1978). Increased risk of lymphoma in sicca syndrome. Ann Int Med 8: 888892.
  • 79
    Kohn W, Ship JA, Atkinson JC, Patton LL, Fox PC (1992). Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Med 8: 7074.
  • 80
    Kruize AA, Hene RJ, Kallenberg CG et al (1993). Hydroxychloroquine treatment for primary Sjogren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 8: 360364.
  • 81
    Leinonen E, Lepola U, Koponen H, Mehtonen OP, Rimon R (1997). Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression. Acta Psychiatr Scand 8: 497504.
  • 82
    LeVeque FG, Montgomery M, Potter D et al (1993). A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 8: 11241131.
  • 83
    Locker D (1993). Subjective reports of oral dryness in an older adult population. Comm Dent Oral Epidemiol 8: 165168.
  • 84
    Loesche WJ, Bromberg J, Terpenning MS et al (1995). Xerostomia, xerogenic medications and food avoidances in selected geriatric groups. J Am Geriatr Soc 8: 401407.
  • 85
    Lopes MA, Kowalski LP, Da Cunha Santos G, Paes de Almeida O (1999). A clinicopathologic study of 196 intraoral minor salivary gland tumours. J Oral Path Med 8: 264267.
  • 86
    Malpani BL, Jaiswar RK, Samuel AM (1999). Noninvasive scintigraphic method to quantify unstimulated secretions from individual salivary glands. Auris Nasus Larynx 8: 453456.
  • 87
    Mandel ID (1980). Sialochemistry in diseases and clinical situations affecting salivary glands. Crit Rev Clin Laboratory Sci 8: 321366.
  • 88
    Mandel ID (1989). The role of saliva in maintaining oral homeostasis. J Am Dent Assoc 8: 298304.
  • 89
    Martin VT, Salmaso R, Onnis GL (1989). Tumors of salivary glands. Review of 479 cases with particular reference to histological types, site, age and sex distribution. Appl Pathol 8: 154160.
  • 90
    Meurman JH, Laine P, Keinanen S, Pyrhonen S, Teerenhovi L, Lindqvist C (1997a). Five-year follow-up of saliva in patients treated for lymphomas. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 447452.
  • 91
    Meurman JH, Laine P, Lindqvist C, Teerenhovi L, Pyrhonen S (1997b). Five-year follow-up study of saliva, mutans streptococci, lactobacilli and yeast counts in lymphoma patients. Oral Oncol 8: 439443.
  • 92
    Meurman JH, Collin HL, Niskanen L et al (1998). Saliva in non-insulin-dependent diabetic patients and control subjects: the role of the autonomic nervous system. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 6976.
  • 93
    Meyerowitz C, Featherstone JD, Billings RJ et al (1991). Use of an intra-oral model to evaluate 0.05% sodium fluoride mouth rinse in radiation-induced hyposalivation. J Dent Res 8: 894898.
  • 94
    Million RR, Cassisi NJ (1994). Management of head and neck cancer, 2nd edn. J. B. Lippincott Co.: Philadelphia.
  • 95
    Nagler RM, Laufer D (1997). Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res 8: 701707.
  • 96
    Narhi TO (1994). Prevalence of subjective feelings of dry mouth in the elderly. J Dent Res 8: 2025.
  • 97
    Navazesh M, Christensen C, Brightman V (1992). Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 8: 13631369.
  • 98
    Nederfors T (1996). Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J Supplement 8: 170.
  • 99
    Nederfors T, Twetman S, Dahlof C (1989). Effects of the thiazide diuretic bendroflumethiazide on salivary flow rate and composition. Scand J Dent Res 8: 520527.
  • 100
    Nederfors T, Ericsson T, Twetman S, Dahlof C (1994). Effects of the beta-adrenoceptor antagonists atenolol and propranolol on human parotid and submandibular-sublingual salivary secretion. J Dent Res 8: 510.
  • 101
    Nederfors T, Dahlof C, Ericsson T, Twetman S (1995). Effects of the antihypertensive drug captopril on human salivary secretion rate and composition. Europ J Oral Sci 8: 351354.
  • 102
    Niedermeier W, Matthaeus C, Meyer C, Staar S, Muller RP, Schulze HJ (1998). Radiation-induced hyposalivation and its treatment with oral pilocarpine. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 541549.
  • 103
    Norman JE, Mitchell RD (1998). Unusual conditions of the major and minor salivary glands. Int J Oral Max Surg 8: 157172.
  • 104
    Oxholm P, Prause JU, Schiodt M (1998). Rational drug therapy recommendations for the treatment of patients with Sjogren's syndrome. Drugs 8: 345353.
  • 105
    Pai S, Ghezzi EM, Ship JA (2001). Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 311316.
  • 106
    Pajukoski H, Meurman JH, Snellman-Grohn S, Keinanen S, Sulkava R (1997). Salivary flow and composition in elderly patients referred to an acute care geriatric ward. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 265271.
  • 107
    Parsons JT (1994). The effect of radiation on normal tissues of the head and neck. In: Million RR, Cassisi NJ, eds. Management of head and neck cancer. A multidisciplinary approach, 2nd edn. J. B. Lippincott Co.: Philadelphia, PA, pp. 245–289.
  • 108
    Patel PS, Ghezzi EM, Ship JA (2001). Xerostomic complaints induced by an anti-sialogogue in healthy young vs. older adults. Spec Care Dent 8: 176181.
  • 109
    Pflugfelder SC (1998). Advances in the diagnosis and management of keratoconjunctivitis sicca. Curr Opin Ophthalmol 8: 5053.
  • 110
    Phillips PP, Olsen KD (1995). Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature. Ann Otol Rhinol Laryngol 8: 100104.
  • 111
    Pillemer SR, Matteson EL, Jacobsson LT et al (2001). Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County. Minnesota Mayo Clin Proc 8: 593599.
  • 112
    Pizzo PA, Meyers J, Freifeld AG, Walsh T (1993). Infections in the Cancer Patient. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 4th edn. J. B. Lippincott Co.: Philadelphia, PA, pp. 2292–2337.
  • 113
    Price EJ, Rigby SP, Clancy U, Venables PJ (1998). A double blind placebo controlled trial of azathioprine in the treatment of primary Sjogren's syndrome. J Rheum 8: 896899.
  • 114
    Proctor GB, Carpenter GH (2001). Chewing stimulates secretion of human salivary secretory immunoglobulin A. J Dent Res 8: 909913.
  • 115
    Rayment SA, Liu B, Offner GD, Oppenheim FG, Troxler RF (2000). Immunoquantification of human salivary mucins MG1 and MG2 in stimulated whole saliva: factors influencing mucin levels. J Dent Res 8: 17651772.
  • 116
    Regelink G, Vissink A, Reintsema H, Nauta JM (1998). Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 8: 383388.
  • 117
    Rhodus NL, Bereuter J (2000). Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjogren's syndrome. J Otolaryngol 8: 2834.
  • 118
    Rieke JW, Hafermann MD, Johnson JT et al (1995). Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Rad Oncol Biol Phys 8: 661669.
  • 119
    Rolston KVI, Bodey GP (1993). Infections in patients with cancer. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR, eds. Cancer medicine, 3rd edn. Lea & Febiger: Philadelphia, PA, pp. 2416–2441.
  • 120
    Royer B, Cazals-Hatem D, Sibilia J et al (1997). Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 8: 766775.
  • 121
    Rubin H, Holt M (1957). Secretory sialography in diseases of the major salivary glands. Am J Roentgenol 8: 575598.
  • 122
    Rudney JD (1995). Does variability in salivary protein concentrations influence oral microbial ecology and oral health? Crit Rev Oral Biol Medical 8: 343367.
  • 123
    Russell SL, Reisine S (1998). Investigation of xerostomia in patients with rheumatoid arthritis. J Am Dent Assoc 8: 733739.
  • 124
    Saito T, Fukuda H, Horikawa M, Ohmori K, Shindoh M, Amemiya A (1997). Salivary gland scintigraphy with 99mTc-pertechnetate in Sjogren's syndrome: relationship to clinicopathologic features of salivary and lacrimal glands. J Oral Pathol Med 8: 4650.
  • 125
    Sathyan G, Chancellor MB, Gupta SK (2001). Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride. Br J Clin Pharmacol 8: 409417.
  • 126
    Schall GL, Anderson LG, Wolf RO et al (1971). Xerostomia in Sjogren's syndrome. Evaluation by sequential salivary scintigraphy. J Am Med Assoc 8: 21092116.
  • 127
    Sciubba JJ (1994). Sjogren's syndrome: pathology, oral presentation, and dental management. Compendium 8: 10841084, 10861086, 10881088 passim; quiz 1096.
  • 128
    Scott J, Flower EA, Burns J (1987). A quantitative study of histological changes in the human parotid gland occurring with adult age. J Oral Path 8: 505510.
  • 129
    Scully C, Epstein JB (1996). Oral health care for the cancer patient. Oral Oncol 8: 281292.
  • 130
    Shay K (1997). Root caries in the older patient: significance, prevention, and treatment. Dent Clin N Am 8: 763794.
  • 131
    Shay K, Truhlar MR, Renner RP (1997). Oropharyngeal candidosis in the older patient. J Am Geriatr Soc 8: 863870.
  • 132
    Ship JA, Baum BJ (1990). Is reduced salivary flow normal in old people? Lancet 8: 15071507.
  • 133
    Ship JA, Fischer DJ (1997). The relationship between dehydration and parotid salivary gland function in young and older healthy adults. J Gerontol Med Sci 8: 310319.
  • 134
    Ship JA, Fox PC, Baum BJ (1991). Normal salivary gland function: how much saliva is enough? J Am Dent Assoc 8: 6369.
  • 135
    Ship JA, Nolan N, Puckett S (1995). Longitudinal analysis of parotid and submandibular salivary flow rates in healthy, different aged adults. J Gerontol Med Sci 8: M285M289.
  • 136
    Ship JA, Pillemer SR, Baum BJ (2002). Xerostomia and the geriatric patient. J Am Geriatr Soc 8: 535543.
  • 137
    Shugars DC, Slade GD, Patton LL, Fiscus SA (2000). Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 432440.
  • 138
    Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM (1996). Methotrexate in primary Sjogren's syndrome. Clin Exper Rheum 8: 555558.
  • 139
    Spiro RH (1997). Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 8: 495498.
  • 140
    Sreebny LM, Schwartz SS (1997). A reference guide to drugs and dry mouth – 2nd edition. Gerodontology 8: 3347.
  • 141
    Stewart CM, Jones AC, Bates RE, Sandow P, Pink F, Stillwell J (1998). Comparison between saliva stimulants and a saliva substitute in patients with xerostomia and hyposalivation. Spec Care Dent 8: 142148.
  • 142
    Stiller M, Golder W, Doring E, Kliem K (1999). Diagnostic value of sialography with both the conventional and digital subtraction techniques in children with primary and secondary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 8: 620627.
  • 143
    Streckfus CF, Wu AJ, Ship JA, Brown LJ (1994). Stimulated parotid gland salivary flow rates in normotensive, hypertensive, and hydrochlorothiazide-medicated African Americans. J Oral Path Med 8: 280283.
  • 144
    Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1997). Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 8: 225232.
  • 145
    Tapinos NI, Polihronis M, Tzioufas AG, Moutsopoulos HM (1999). Sjogren's syndrome. Autoimmune epithelitis. Adv Exp Med Biol 8: 127134.
  • 146
    Terpenning M, Bretz W, Lopatin D, Langmore S, Dominguez B, Loesche W (1993). Bacterial colonization of saliva and plaque in the elderly. Clin Infect Dis 8 (Suppl. 4): S314S316.
  • 147
    Thomas E, Hay EM, Hajeer A, Silman AJ (1998). Sjogren's syndrome: a community-based study of prevalence and impact. Br J Rheum 8: 10691076.
  • 148
    Thomson WM, Chalmers JM, Spencer AJ, Ketabi M (1999). The occurrence of xerostomia and salivary gland hypofunction in a population-based sample of older South Australians. Spec Care Dent 8: 2023.
  • 149
    Trindade E, Menon D, Topfer LA, Coloma C (1998). Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Can Med Assoc J 8: 12451252.
  • 150
    Valdez IH, Atkinson JC, Ship JA, Fox PC (1993). Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Rad Oncol Biol Phys 8: 4147.
  • 151
    Vissink A, Spijkervet FK, Van Nieuw Amerongen A (1996). Aging and saliva: a review of the literature. Spec Care Dent 8: 95103.
  • 152
    Vitali C, Bombardieri S, Moutsopoulos HM et al (1996). Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre Study. The European Study Group on diagnostic criteria for Sjogren's syndrome. Ann Rheum Dis 8: 116121.
  • 153
    Vivino FB, Al-Hashimi I, Khan Z et al (1999). Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial: P92–01 Study Group. Arch Int Med 8: 174181.
  • 154
    Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, (1999). Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's syndrome. Arthritis Rheum 8: 17651772.
  • 155
    Wang SL, Zhao ZT, Li J, Zhu XZ, Dong H, Zhang YG (1998). Investigation of the clinical value of total saliva flow rates. Arch Oral Biol 8: 3943.
  • 156
    Warde P, Kroll B, O'Sullivan B et al (2000). A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Care Cancer (Suppl.) 8: 203208.
  • 157
    Williams HK, Connor R, Edmondson H (2000). Chronic sclerosing sialadenitis of the submandibular and parotid glands: a report of a case and review of the literature. Oral Surg Oral Med Oral Path Oral Radiol Endod 8: 720723.
  • 158
    Wu AJ, Atkinson JC, Fox PC, Baum BJ, Ship JA (1993). Cross-sectional and longitudinal analyses of stimulated parotid salivary constituents in healthy different aged subjects. J Gerontol Med Sci 8: M219M224.
  • 159
    Wu AJ, Ship JA (1993). A characterization of major salivary gland flow rates in the presence of medications and systemic diseases. Oral Surg Oral Med Oral Pathol 8: 301306.
  • 160
    Yamano S, Baum BJ (2000). Prospects for gene-based immunopharmacology in salivary glands. Jap J Pharmacol 8: 281286.
  • 161
    Yeh CK, Johnson DA, Dodds MW, Sakai S, Rugh JD, Hatch JP (2000). Association of salivary flow rates with maximal bite force. J Dent Res 8: 15601565.
  • 162
    Zimmerman RP, Mark RJ, Tran LM, Juillard GF (1997). Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Rad Oncol Biol Phys 8: 571575.
  • 163
    Zwetchkenbaum SR, Shay K (1997). Prosthodontic considerations for the older patient. Dent Clin N Am 8: 817846.